Eosinophils and activation markers after allergen challenge - a pilot study for three-dimensional analysis in the bronchial mucosa

Allergy. 2021 Sep;76(9):2907-2910. doi: 10.1111/all.14909. Epub 2021 Jun 4.

Frauke Prenzler¹, Thomas Tschernig², Katherina Sewald^{1

3}, Tibor Z Veres^{1

4}, Susanne Rittinghausen^{1

3}, Norbert Krug^{1

3}, Jens M Hohlfeld^{1

3

5}, Armin Braun^{1

3

6}

¹ Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
² Institute for Cell Biology and Anatomy, Saarland University, Saarbrucken, Germany.
³ Member of the German Center for Lung Research (DZL), Biomedical Research in End-stage and Obstructive Lung Disease (BREATH) research network, Hannover, Germany.
⁴ Lymphocyte Biology Section, Laboratory of Immune System Biology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
⁵ Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
⁶ Institute of Immunology, Hannover Medical School, Hannover, Germany.

No abstract available

Keywords: asthma; eosinophils; inflammation; interleukins.

Publication types